Waystar Holding Corp. WAY 深 沪
等待开盘 05-20 09:30:00 美东时间
19.60
+1.050
+5.66%
华盛通- 最 高20.39
- 今 开19.56
- 成交量 307.07万股
- 最 低 19.235
- 昨 收 18.55
- 总市值 37.60亿
- 52周最高 41.49
- 市盈率 静 32.31
- 换手率 1.60%
- 52周最低 17.89
- 委 比 -9.04%
- 总股本 1.92亿
- 历史最高 48.11
- 量 比 1.29
- 振 幅 6.23%
- 历史最低 17.89
- 每 手 1
- 风险率 6.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Waystar, Bakkt, Snowflake And Other Big Stocks Moving Higher On Tuesday
U.S. stocks lower, Nasdaq down 1%. Waystar Holding shares rise 7.8% after $200M stock repurchase plan announcement. Other top gainers include Agilysys, Bakkt, Enhanced Group, and more.
05-19 22:18
Waystar sets $200M stock repurchase plan
Waystar (WAY) board of directors authorized a stock repurchase plan for up to $200M of the company's common stock. The stock repurchase plan does not obligate the company to acquire any particular amo...
05-19 20:32
Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook
LEHI, Utah and LOUISVILLE, Ky., May 19, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that its Board of Directo...
05-19 20:00
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
美股周涨跌榜 | 净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%
累计净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%，Q1营收同比翻倍大超预期>>
05-04 18:33
美股夜盘 | NovoCure Ltd.涨27.41%，Impinj, Inc.涨24.95%
NovoCure Ltd.涨27.41%；Impinj, Inc.涨24.95%；Atlassian涨23.36%
05-01 15:01
美股夜盘 | NovoCure Ltd.涨27.41%，Twilio涨25.18%
NovoCure Ltd.涨27.41%；Twilio涨25.18%；Impinj, Inc.涨24.95%
05-01 13:01
美股大行评级 | 潜在涨幅128.69%！Immunic获HC Wainwright & Co.升目标价至22美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immunic"买入"评级，目标价从5美元升至22美元；花旗：维持ServiceNow"买入"评级，目标价从154美元升至158美元
05-01 10:49
Waystar Holding Corp. Signals AI-Fueled Growth Ahead
Waystar Holding Corp. (($WAY)) has held its Q1 earnings call. Read on for the m...
05-01 09:10
Needham Reiterates Buy on Waystar Holding, Maintains $33 Price Target
Needham analyst Ryan MacDonald reiterates Waystar Holding (NASDAQ:WAY) with a Buy and maintains $33 price target.
04-30 20:22
